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Objectives: Sarcopenia is one of common problems among elderly worldwide. To determine the prevalence of sarcopenia and related factors in
community-dwelling elders Thai population.
Methods: This cross-sectional study was performed in 243 subjects aged over 60 years. All participants were evaluated for handgrip strength by
dynamometer and for gait speed by walking a 6-m distance. The muscle mass for subjects who had abnormal grip strength and/or gait speed was
evaluated by bioimpedance analysis (BIA). The prevalence of sarcopenia was calculated and factors related to sarcopenia were also analyzed.
Results: The mean age was 69.7 ± 6.9 years with three-fourths female participants. Approximate 60% of subjects were overweight. There were
74 participants (30.5%, (95% CI: 25.0%e36.5%)) with abnormal grip strength; gait speed and muscle mass. Males had more prevalence than
females (33.9% vs. 29.3% respectively). There is higher prevalence with increasing age among both genders (17.9%, 41.4% and 80.0% in young
old, middle old, and the very old groups respectively in male; and 11.5%, 49.1%, and 65.0% in female). After using multivariate analysis, age,
body mass index (BMI), and quadriceps strengths were significantly related to sarcopenia with the adjusted odds ratio of 15.47 (95% CI: 4.93,
48.54), 12.84 (95% CI: 3.85, 42.82) and 3.77 (95% CI: 1.70, 8.37) respectively.
Conclusions: Thirty percent of the community-based elderly experienced sarcopenia. As the prevalence is high, the screening for sarcopenia
should be performed in community-dwelling elders especially older age, underweight subjects and lower quadriceps strength.
© 2016 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).physical performance [1]. The International Working Group
on Sarcopenia proposed definition of sarcopenia in 2009 as
“age-associated loss of skeletal muscle mass and functions
which were strength and performance as well” [2]. Nowadays,
sarcopenia becomes public interest and is recognized world-
wide. Its consequences greatly impact on muscle performance,
functional decline, physical disability, poor quality of life and
even death in some patients. It can affect the ability to maintain
an active lifestyle and associate with mobility limitation [3].
Furthermore, the healthcare costs for sarcopenia is high.
Janssen and colleagues reported the estimated directlsevier B.V. This is an open access article under the CC BY-NC-ND license
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2000 (1.5% of total healthcare expenditure) [4], the healthcare
cost was in excess of $860e933 for every client with sarco-
penia. A 10% reduction in the prevalence of sarcopenia can
save $1.1 billion dollars per year. This represents very high
healthcare costs in USA. As sarcopenia is commonly found in
elderly with advancing age, prevalence of sarcopenia is an
important societal and public health concern.
Many studies reported the prevalence of sarcopenia which
varied in method, criteria or type of elderly. Cruz-Jentoft and
colleagues performed asystemic review published in 2014 on
the prevalence on sarcopenia which ranged from 1 to 29% of
the older adults living in the community [5]. In addition, this
number increased to 14e33% for the long-term care older
residents [6,7]. In rehabilitation setting, the prevalence was
higher up to 60% among elder patients admitted in rehabili-
tation ward [8].
Besides from the prevalence of sarcopenia, factors related
to it were also crucial. Concerning to those factors, some
studies reported age, gender and level of physical activities as
factors related to sarcopenia [9,10]. Beasley et al. mentioned
the risk factors for sarcopenia as age, malnutrition and phys-
ical inactivity [11]. Furthermore, some believed its causes
were from multiple factors including disuse, malnutrition, age-
related cellular changes, apoptosis, and genetic predisposition
as presented by Hida and colleagues [12]. Walston JD also
reported multiple factors such as neurological decline, hor-
monal changes, inflammatory pathway activation, declines in
activity, chronic illness, fatty infiltration, and poor nutrition
served as contributing factors to sarcopenia [3].
As sarcopenia is one of themajor health problems in aging, the
current study objectives were to investigate the prevalence of
sarcopenia incommunity-dwellingThai eldersand related factors.
2. Methods
This study has a cross-sectional design. In April 2015,
personnel from Department of Rehabilitation Medicine, Fac-
ulty of Medicine Siriraj Hospital performed corporeal social
responsibility (CSR) activity in Ampawa Province, Samut-
songkram, in central Thailand. “CSR” means any activities
that an organization performs for the sake of humanity with
respect to society. Staff in our department volunteered to
create health activity among community-residing elderly aged
more than 60 years. Our activities were to investigate health
status and giving health education about the common
musculoskeletal diseases in elderly including sarcopenia,
osteoarthritis, osteoporosis, and fall prevention. To avoid se-
lection bias, all participants were elderly who could walk and
join our activity at the city hall of Ampawa Province. This
study was approved by the Ethical Review committee of the
Faculty of Medicine, Siriraj Hospital.
Demographic data including age, sex, body weight, height,
and underlying diseases were recorded. Those underlying
diseases were diagnosed by their primary doctor. Fall fre-
quency was assessed by asking participants with the sentence
“Have you ever had a fall (or falls) this year?” In addition, thebody mass index was calculated from weight/height (meter)2
and was categorized into 3 groups: underweight
(BMI < 18.5 kg/m2), normal (BMI ¼ 18.5e23.0 kg/m2) and
overweight (BMI> 23.0 kg/m2) [13]. To investigate health
status, the quadriceps strength of dominant leg was measured
twice in a sitting position by using hand-held dynamometer,
Lafayette Manual Muscle Test System (MMT)® model 01163
(Lafayette Instruments, Lafayette, IN, USA). The maximal
value was selected. The cut-off value for quadriceps strength
in male and female were 18.0 and 16.0 kg respectively [14].
For assessment of physical performance, grip strength and
gait speed were evaluated. Grip strength was measured by using
hand-held dynamometer (Jamar hand dynamometer, Preston
Jackson, Michigan, 49203, USA). Participants sit upright,
adducted arms beside trunk and flexed elbows 90. They were
asked to hold hand dynamometer tightly and squeezed as
strongly as they could. They were allowed to practice once
before testing. Then, the grip strength was tested in dominant
hand twice, and the maximal value was selected. The cut-off
values in male and female were 26 kg and 18 kg respectively
[15]. The gait speed was evaluated by asking participants to
walk 10-m distance. Time was recorded from the2-meter to 8-
m marker. Then, the gait speed was calculated from time
using in 6-m walk with the cut-off value of 0.8 m/s [16].
Participants who had abnormal handgrip strength and/or
gait speed were evaluated for lean body mass by using Bio-
impedance Analyzer Model 450 (Biodynamics, Seattle, WA,
USA). We calculated lean body mass from percentage of
whole body skeletal mass multiplied by body weight, and
divided by 100. The one who had lean body mass less than
7 kg/m2 in male or 5.7 kg/m2 in female were considered
abnormal muscle mass [15]. Then, the prevalence of sarco-
penia was calculated. In addition, the prevalence categorized
by different gender, different age groups (young old: 60e69
years; middle old: 70e79 years; the very old: 80 years) and
among different gender and different age groups, were done.
The factors related to sarcopenia were analyzed including age,
sex, body mass index (BMI), history of falls and quadriceps
strength.2.1. Statistical analysisThe continuous data was presented as mean ± standard
deviation (SD). The categorical data was presented as number
(n) and percentage (%). Univariate factors related to sarco-
penia were analyzed using chi-square test. Multiple logistic
regression was used to adjust for confounding for multivariate
analysis. The strength of association was measured using odds
ratio (OR) with 95% confidence intervals (95% CI). The p-
value of <0.05 was considered statistically significant. Data
analysis was performed with PASW Statistics (SPSS) 18.0
(SPSS Inc., Chicago, IL, USA).
3. Results
The total number was 243 elder participants with a mean
(SD) of 69.7 (6.9) years. Three-fourths of participants were
Table 1
Demographic data of all study participants.
Demographic data n ¼ 243
Age (y) 69.7 ± 6.9
Age (y)
60e69 132 (54.3)
70e79 86 (35.4)
80 25 (10.3)
Sex
Male 62 (25.5)
Female 181 (74.5)
Body mass index
Underweight (<18.5 kg/m2) 21 (8.6)
Normal (18.5e23.0 kg/m2) 77 (31.7)
Overweight (>23.0 kg/m2) 145 (59.7)
Underlying diseases
Diabetes mellitus 47 (19.3)
Hypertension 134 (55.1)
Hyperlipidemia 89 (36.6)
Knee osteoarthritis 88 (36.2)
Back pain 107 (44.0)
Fragility fracture from fall 12 (4.9)
Data are presented as mean ± standard deviation or n (%).
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The common underlying diseases were hypertension (55.1%),
back pain (44.0%), hyperlipidemia (36.6%), knee osteoar-
thritis (36.2%) and diabetes mellitus (19.3%) (Table 1). Table
2 presents mean and SD of grip strength, gait speed and
muscle mass categorized by cut-point values and gender.
Males had significantly higher values than females in all
variables except in abnormal gait speed among male and fe-
male groups. (p ¼ 0.504).
Fig. 1 shows diagram of screening for sarcopenia in 243
community-based elderly. Seventy-eight subjects (32.1%) had
abnormal gait speed and 49 (20.2%) had abnormal grip
strength. Then, 127 participants with abnormal gait and grip
strength were evaluated for BIA. After performing BIA, only
74 subjects had muscle mass below cutoff value. Therefore,
the prevalence of sarcopenia was 30.5% (74 from 243) (95%
CI: 25.0%e36.5%). Fig. 2 presents the prevalence of sarco-
penia among different gender. Male has more prevalent than
female (33.9% vs. 29.3% respectively). Concerning age, there
is increasing trend when participants get older (12.9% inTable 2
Grip strength, gait speed, and muscle mass of all participants and participants cate
Para-meters Groups Cut-off values n
Grip strength Normal M >26 kg
F >18 kg
154
Abnormal M 26 kg
F 18 kg
89
Gait speed Normal >0.8 m/s 165
Abnormal 0.8 m/s 78
Muscle mass Normal M >7.0 kg/m2
F >5.7 kg/m2
53
Abnormal M 7.0 kg/m2
F 5.7 kg/m2
74
Data are presented as mean ± standard deviation unless otherwise indicated.
M, male; F, female.young old, 46.5% in middle old, and 68.0% in the very old
groups) (Fig. 3). Fig. 4 presents prevalence of sarcopenia
among different gender and different age groups. Our results
show increasing trend with increasing age among both gender
(17.9%, 41.4% and 80.0% in young old, middle old, and the
very old groups respectively in male; and 11.5%, 49.1%, and
65.0% in female).
Table 3 shows factors related to sarcopenia using univariate
and multivariate analysis including age, sex, BMI, history of
fall and quadriceps strength. After adjusted for multiple fac-
tors, only age, BMI, and quadriceps strength were significantly
related to sarcopenia with the adjusted odds ratio of 15.47
(95% CI: 4.93, 48.54), 12.84 (95% CI: 3.85, 42.82) and 3.77
(95% CI: 1.70, 8.37) respectively.4. Discussion
The European Working Group on Sarcopenia in Older
People (EWGSOP) defined term of sarcopenia as a syndrome
characterized by progressive and generalized loss of skeletal
muscle mass and strength with a risk of adverse outcomes such
as physical disability, poor quality of life and death [5]. As
sarcopenia had an impact on health and quality of life, the
study of prevalence provides information to guide direction of
health care services in our country. The prevalence of sarco-
penia in this study was 30.5% with male preference than fe-
male (33.9% vs. 29.3%). This prevalence was in line with the
study of Landi et al. who reported that sarcopenia seemed to
be related with gender; especially more commonly occurred in
males than female (68% vs. 21%), but their study was per-
formed among nursing home older residents [6]. In the
following year, Landi et al. did a study in the community-
dwelling elders and reported the prevalence of 29.1% with
more prevalence in female than in male (30.1% vs. 27.1%)
[17]. However, they measured muscle mass by using mid-arm
muscle circumference technique which was different from our
study.
A study from China reported the prevalence of sarcopenia
in community-dwelling of 9.8% (12.0% for female and 6.7%
for male). It also presents higher prevalence in rural elders
than in urban elders (13.1% vs. 7.0%) [18]. Another studygorized by sex.
Total Male Female p
25.2 ± 6.2 34.2 ± 5.0 22.9 ± 3.8 <0.001
16.8 ± 4.7 21.2 ± 4.6 14.6 ± 2.8 <0.001
1.00 ± 0.16 1.07 ± 0.20 0.98 ± 0.13 0.005
0.65 ± 0.12 0.67 ± 0.10 0.65 ± 0.12 0.504
6.9 ± 1.3 8.3 ± 1.6 6.5 ± 0.8 0.012
5.1 ± 0.8 5.7 ± 0.8 4.8 ± 0.6 <0.001
Gait speed
Normal speed
(> 0.8 m/sec)
N =165 (67.9%)
Abnormal speed
(≤ 0.8 m/sec)
N = 78 (32.1%)
Grip strength Muscle mass
Normal grip
(Male > 26, Female>18)
Abnormal grip
(Male ≤ 26, Female ≤18)
N = 53 (21.8%)
Abnormal mass
(Male ≤ 7, Female ≤ 5.7)
N =116 (47.7%) N = 49 (20.2%)
Normal mass
(Male > 7, Female > 5.7)
N = 74 (30.5%)
Normal
N = 169 (69.5%)
Total 243
Fig. 1. Diagram of screening for sarcopenia in older community-based participants.
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Fig. 3. Prevalence of sarcopenia among different age groups.
17.9%
41.4%
80.0%
11.5%
49.1%
65.0%
0%
20%
40%
60%
80%
100%
60-69 70-79 80+
ainepocraSfo
ecnelaverP
(%
)
Age (y)
Male
Female
Fig. 4. Prevalence of sarcopenia between different sexes and among different
age groups.
113N. Khongsri et al. / Osteoporosis and Sarcopenia 2 (2016) 110e115from Germany which was performed in community-dwelling
women aged 70 years and older, presents the prevalence of
4.5% (2.8% in age 70e79 years vs. 9.9% in age 80 years)
[19] which was lower than ours. This may be because they
used lower cut-off value (normal grip 20 kg, normal musclemass >5.66 kg/m2) compared to ours (normal grip in male
>26, and in female >18 kg; normal muscle mass in male
>7 kg/m2, and in female >5.7 kg/m2), so the number of
abnormal participants was less than our study. There are two
studies from Japan which reported the prevalence of sarco-
penia using BIA for measurement of muscle mass of 10.7%e
22.1% [20,21]. The prevalence in our study was higher than
the other studies from Asian countries. This may come from
different cut-off value. This issue should be concerned to use
standardized cut-off value, therefore, we can compare the re-
sults among countries.
Pongchaiyakul and colleagues reported the prevalence of
sarcopenia in the Thai population using the skeletal muscle
index (SMI) criteria [22]. They found the prevalence among
men and women was 35.33% (95% CI: 29.91, 40.41) and
34.74% (95% CI: 30.56, 39.10) respectively, which was close
to our results. In addition, they also found three factors
Table 3
Factors related to sarcopenia in univariate and multivariate analyses.
Factors Sarcopenia Crude odds ratio (95% CI)a Adjusted odds ratio (95% CI)b
Yes (n ¼ 74) No (n ¼ 169)
Age (y)
60e69 17 (23.0) 115 (68.0) 1.00 1.00
70e79 40 (54.1) 46 (27.2) 5.88 (3.03e11.41)c 6.19 (2.91e13.18)c
80 17 (23.0) 8 (4.7) 14.37 (5.38e38.40)c 15.47 (4.93e48.54)c
Sex
Male 21 (28.4) 41 (24.3) 1.00 e
Female 53 (71.6) 128 (75.7) 0.81 (0.44e1.50)
Body mass index
>23.0 kg/m2 24 (32.4) 121 (71.6) 1.00 1.00
18.5e23.0 kg/m2 36 (48.7) 41 (24.3) 4.43 (2.37e8.28)c 4.70 (2.23e9.92)c
<18.5 kg/m2 14 (18.9) 7 (4.1) 10.08 (3.68e27.62)c 12.84 (3.85e42.82)c
History of falls
0e1 61 (83.6) 148 (88.1) 1.00 e
2 12 (16.4) 20 (11.9) 1.46 (0.67e3.16)
Quadriceps strengthd
Normal 43 (60.6) 138 (84.1) 1.00 1.00
Abnormal 28 (39.4) 26 (15.9) 3.46 (1.83e6.52)c 3.77 (1.70e8.37)c
Data are presented as n (%) unless otherwise indicated.
CI, confidence interval.
a Chi-square test.
b Multiple logistic regression.
c Statistically significant.
d Normal quadriceps strength: >18 kg in males and >16 kg in females.
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area, higher BMI, and older age. Their results confirmed that
sarcopenia increases with age. Most studies in the systematic
review suggested that the prevalence of sarcopenia increased
with age [5]. Our results also presented increasing trend ac-
cording to age, both in male and female. This may due to loss
of muscle mass when they aged. There were evidences con-
cerning progressive loss of muscle mass after age of 60 years
and accelerating after age of 75 years [23,24].
Concerning the factors related to sarcopenia, we found that
older age, low BMI and low quadriceps strength were asso-
ciated with sarcopenia. This was in line with the other studies
[25e28]. For example, Senior et al. performed study in
nursing home elderly and reported that only BMI is a pre-
dictive factor for sarcopenia (OR 0.8; 95% CI: 0.65, 0.97)
[25]. In addition, Yalcin et al. also found that BMI and calf
circumference were associated with sarcopenia [26]. Older age
was another important factors as presented by Martinez et al.
(OR 1.14; 95% CI: 1.06, 1.23) [27]. Han et al. also reported
the factors related to sarcopenia as older age for both genders
and inversely associated with BMI for both genders as well
[28]. Furthermore, Santilli and colleague reported risk factors
for sarcopenia including age, gender and level of physical
activity. Elders with low physical activity or inactivity, loss of
their muscle mass and also strength [9]. Therefore, they sug-
gested aging to be physically active which could be a pro-
tective factor for sarcopenia.
One of the major components of sarcopenia was age-related
decline in muscle mass. It can cause mobility limitations,
functional decline, disability and dependency. Not only
changes in muscle mass but also muscle quality occurred with
aging [29]. Our result found that quadriceps strength was oneof factors related to sarcopenia. This may be explained that
quadriceps strength play a major role for walking and
balancing which represent physical performance especially
gait speed in elderly [30,31]. de Oliveira and colleague
examined the association between quadriceps strength and
sarcopenia with aerobic fitness indexes in 189 elderly women.
They reported that elderly with sarcopenia presented signifi-
cantly lower muscle strength and VO2 peak when compared to
non-sarcopenic patients [32]. Therefore, quadriceps-
strengthening exercises should be emphasized to improve
functions of lower extremities in sarcopenia. Finally, our study
could not find any novel risk factors, therefore we confirm that
older age, low BMI and low quadriceps strength are important
clinical risk factors.
There were some limitations of this study including selec-
tion bias as all participants were elders who could walk and
join our activity at the City Hall of Ampawa Province. In
addition, the machine used to measure muscle mass was
portable BIA which could not measure appendicular weight,
therefore we used whole body muscle mass instead of limb
mass. Furthermore, the generalizability of the findings had
some limitation because we recruited subjects at only one
community which may not be directly representative of Thai
elderly. More studies that recruit elderly from the other parts
including northern, north-eastern, central and southern parts of
Thailand, should be performed.
5. Conclusion
The prevalence of sarcopenia in community-dwelling
elders in Thailand was quite high (approximately one-
third). Factors related to sarcopenia were age, BMI and
115N. Khongsri et al. / Osteoporosis and Sarcopenia 2 (2016) 110e115quadriceps strength. Resistive exercise for improving quadri-
ceps strength should be emphasized to improve functions of
lower extremities in sarcopenia.
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